1,000 filings
Page 7 of 50
SC 13G/A
ryt14fxr4i
10 Feb 22
SEELOS THERAPEUTICS / VANGUARD ownership change
12:00am
SC 13G
od28m bbd0oe8zcsxh3
4 Feb 22
SEELOS THERAPEUTICS / BlackRock ownership change
12:00am
S-8
h8el orqcoxox
18 Jan 22
Registration of securities for employees
5:12pm
4
32u34as ecx74
11 Jan 22
SEELOS THERAPEUTICS / Raj Mehra ownership change
4:29pm
4
3uexivy
11 Jan 22
SEELOS THERAPEUTICS / Michael Joseph Golembiewski ownership change
4:27pm
8-K
kf7guspc lz
10 Jan 22
Departure of Directors or Certain Officers
4:28pm
4
sq308b2 6xp
6 Jan 22
SEELOS THERAPEUTICS / Richard W Pascoe ownership change
8:07pm
4
7hy x0a4mr25hp6z0jef
6 Jan 22
SEELOS THERAPEUTICS / Daniel J. O'Connor ownership change
8:06pm
4
mxavy0pn ru
6 Jan 22
SEELOS THERAPEUTICS / MARGARET DALESANDRO ownership change
8:04pm
4
rneihg8r5y i6c0dh
6 Jan 22
SEELOS THERAPEUTICS / Brian Lian ownership change
8:02pm
EFFECT
9yb 59fjyaa
28 Dec 21
Notice of effectiveness
12:15am
424B3
ydhovxos9v0dtjqz0h
27 Dec 21
Prospectus supplement
5:01pm
CORRESP
42maywyc
22 Dec 21
Correspondence with SEC
12:00am
UPLOAD
pn0 rp4kia
21 Dec 21
Letter from SEC
12:00am
8-K
7wy8p5cj559
24 Nov 21
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma’s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
8:20am
8-K
m9h1pykn
24 Nov 21
Entry into a Material Definitive Agreement
7:27am
8-K
u6m6uzff93n3
25 Oct 21
Seelos Therapeutics Presents a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide Research
2:03pm
4
9tf7honjn3rc vw
2 Sep 21
SEELOS THERAPEUTICS / MARGARET DALESANDRO ownership change
4:08pm